What sets our protocol apart
Evidence-led, holistic, and fully customized.
There is no guessing when it comes to our protocol — every case is evaluated and treated against the published evidence and the patient in front of us.
Research
Our protocol is grounded in the published literature on mesenchymal and stem-cell therapies — and refined over thousands of successful cases. Below is a curated selection of the peer-reviewed studies that inform our approach.
RegenCore’s approach is based on the latest published research and refined over thousands of successful regenerative therapy treatments. We hold ourselves to conservative, evidence-led claims — the studies below are external, peer-reviewed work on mesenchymal and stem-cell therapies that inform how and when we apply orthobiologic treatment.
Where the on-site evidence is quantified, we cite it plainly: a prospective study of severe knee osteoarthritis reported a 95% success rate at four-year follow-up with bone marrow concentrate, more than 80% of erectile-dysfunction patients see some improvement with our combination protocol, and most spinal-decompression patients notice improvement after 6–10 sessions. Most regenerative studies report only 12–24 month outcomes; longer follow-up is still needed.
Curated literature
These are external, peer-reviewed studies that inform our protocol — not original RegenCore research. We do not assign success rates to them beyond what each study reports.
What sets our protocol apart
There is no guessing when it comes to our protocol — every case is evaluated and treated against the published evidence and the patient in front of us.
Book a concierge evaluation in San Francisco or Palo Alto.